ClinicalTrials.Veeva

Menu

Comparison of Two High Performance Guidewires in ERCP

J

Johann Wolfgang Goethe University Hospital

Status

Completed

Conditions

Stenosis of Bile Duct

Treatments

Device: VisiGlide™ angled tip
Device: VisiGlide2™ angled tip
Device: VisiGlide2™ straight tip
Device: VisiGlide™ straight tip

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In ERCP guidewires are used for the insertion of endoprostheses and the cannulation of stenosis. This leads to two essential requirements for the wire systems: The use of a (highly) flexible, hydrophilic wire to achieve successful and rapid passage of the narrow passage; for additional intervention, modern wires are equipped with a stable shaft with which e.g. bougies, dilatation catheters, or stents can be introduced. Guidewires are available with angled or straight tips whose use differ regionally. Guidewires with angled tips are used predominantly in Japan, whereas in the Western world incl. Germany straight wires are commonly used. In a recently published study examining the intubation of the native papilla, successful intubation of the papilla was faster with guidewires with angled tips than with guidewires with straight tips. However, this did not result in an effect upon the time-independent rate of the successful papilla intubation.

The investigators test the hypothesis that 1) a higher success rate of the ERCP can be achieved with the use of an angled guidewire than with a straight guidewire and 2) a higher success rate of the ERCP can be achieved with the use of a type 1 guidewire than with a type 2 guidewire

Full description

This is a randomized, multicentric study.

Enrollment

453 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data

Exclusion criteria

  • Operatively alternated anatomy of the patient

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

453 participants in 4 patient groups

guidewire type 1: VisiGlide™ angled tip
Active Comparator group
Description:
Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)
Treatment:
Device: VisiGlide2™ straight tip
Device: VisiGlide™ straight tip
Device: VisiGlide2™ angled tip
Device: VisiGlide™ angled tip
guidewire type 2: VisiGlide2™ angled tip
Active Comparator group
Description:
Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)
Treatment:
Device: VisiGlide2™ straight tip
Device: VisiGlide™ straight tip
Device: VisiGlide2™ angled tip
Device: VisiGlide™ angled tip
guidewire type 1: VisiGlide™ straight tip
Active Comparator group
Description:
Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)
Treatment:
Device: VisiGlide2™ straight tip
Device: VisiGlide™ straight tip
Device: VisiGlide2™ angled tip
Device: VisiGlide™ angled tip
guidewire type 2: VisiGlide2™ straight tip
Active Comparator group
Description:
Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)
Treatment:
Device: VisiGlide2™ straight tip
Device: VisiGlide™ straight tip
Device: VisiGlide2™ angled tip
Device: VisiGlide™ angled tip

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems